Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Cl B (HUGE)

Fsd Pharma Inc Cl B (HUGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,548
  • Shares Outstanding, K 40,117
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,900 K
  • 60-Month Beta 0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.50
Trade HUGE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings $-0.05 on 05/14/24
  • Next Earnings Date 07/18/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -684.57%)
  • Historical Volatility 88.36%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,028.08% on 07/16/24
  • IV Low 0.00% on 07/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 2,726
  • Open Int (30-Day) 3,954

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1300 +6.23%
on 07/02/24
0.1998 -30.88%
on 06/25/24
-0.0329 (-19.24%)
since 06/21/24
3-Month
0.1300 +6.23%
on 07/02/24
0.5200 -73.44%
on 04/25/24
-0.3509 (-71.76%)
since 04/22/24
52-Week
0.1300 +6.23%
on 07/02/24
1.6799 -91.78%
on 09/18/23
-1.0119 (-87.99%)
since 07/21/23

Most Recent Stories

More News
FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 0.1381 (-0.14%)
HUGE.CN : 0.1900 (unch)
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 0.1381 (-0.14%)
HUGE.CN : 0.1900 (unch)
DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION

/PRNewswire/ -- Attorneys for Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma (CSE: HUGE, NASDAQ: HUGE) have filed two new claims against...

HUGE : 0.1381 (-0.14%)
DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION

/CNW/ -- Attorneys for Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma (CSE: HUGE, NASDAQ: HUGE) have filed two new claims against his...

HUGE.CN : 0.1900 (unch)
HUGE : 0.1381 (-0.14%)
FSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.1381 (-0.14%)
HUGE.CN : 0.1900 (unch)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END

CELH : 48.14 (-2.90%)
RXDX : 199.92 (+0.09%)
HUGE : 0.1381 (-0.14%)
OMER : 5.10 (+4.51%)
MRK : 125.69 (-0.06%)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

/PRNewswire/ -- Alcohol consumption and drug abuse have become public health concerns worldwide. Governments are working on ways to detect any symptoms of...

CELH : 48.14 (-2.90%)
HUGE : 0.1381 (-0.14%)
OMER : 5.10 (+4.51%)
MRK : 125.69 (-0.06%)
RXDX : 199.92 (+0.09%)
FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.1381 (-0.14%)
HUGE.CN : 0.1900 (unch)
FSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.1381 (-0.14%)
HUGE.CN : 0.1900 (unch)
FSD Pharma Announces Filing of Year-End 2022 Results

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.1381 (-0.14%)
HUGE.CN : 0.1900 (unch)

Business Summary

FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

See More

Key Turning Points

3rd Resistance Point 0.1464
2nd Resistance Point 0.1435
1st Resistance Point 0.1408
Last Price 0.1381
1st Support Level 0.1352
2nd Support Level 0.1323
3rd Support Level 0.1296

See More

52-Week High 1.6799
Fibonacci 61.8% 1.0878
Fibonacci 50% 0.9050
Fibonacci 38.2% 0.7221
Last Price 0.1381
52-Week Low 0.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar